- Home
- ARMP vs MIND Comparison
ARMP vs MIND Comparison
Compare ARMP & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- MIND
- Stock Information
- Founded
- ARMP N/A
- MIND 1987
- Country
- ARMP United States
- MIND United States
- Employees
- ARMP N/A
- MIND N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- MIND Industrial Machinery/Components
- Sector
- ARMP Health Care
- MIND Industrials
- Exchange
- ARMP Nasdaq
- MIND Nasdaq
- Market Cap
- ARMP 92.4M
- MIND 85.5M
- IPO Year
- ARMP N/A
- MIND 1994
- Fundamental
- Price
- ARMP $2.86
- MIND $8.66
- Analyst Decision
- ARMP Strong Buy
- MIND
- Analyst Count
- ARMP 1
- MIND 0
- Target Price
- ARMP $9.00
- MIND N/A
- AVG Volume (30 Days)
- ARMP 12.1K
- MIND 224.0K
- Earning Date
- ARMP 11-12-2025
- MIND 09-09-2025
- Dividend Yield
- ARMP N/A
- MIND N/A
- EPS Growth
- ARMP N/A
- MIND N/A
- EPS
- ARMP N/A
- MIND 2.54
- Revenue
- ARMP $6,868,000.00
- MIND $48,612,000.00
- Revenue This Year
- ARMP $8.43
- MIND $7.27
- Revenue Next Year
- ARMP N/A
- MIND N/A
- P/E Ratio
- ARMP N/A
- MIND $3.22
- Revenue Growth
- ARMP 84.67
- MIND 27.70
- 52 Week Low
- ARMP $0.90
- MIND $3.47
- 52 Week High
- ARMP $3.14
- MIND $11.50
- Technical
- Relative Strength Index (RSI)
- ARMP 57.54
- MIND 43.44
- Support Level
- ARMP $2.79
- MIND $8.01
- Resistance Level
- ARMP $3.03
- MIND $9.87
- Average True Range (ATR)
- ARMP 0.16
- MIND 0.63
- MACD
- ARMP 0.01
- MIND -0.24
- Stochastic Oscillator
- ARMP 62.16
- MIND 23.74
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.